Vaginal Mesh
In 2016, the FDA reclassified transvaginal mesh used to repair pelvic organ prolapse (POP) as a Class III device—the highest risk category—in response to over 20,000 adverse event reports during a three-year period alone.
Yesterday’s announcement that the FDA is requiring clinical trials of vaginal mesh used for pelvic organ prolapse is good news for women!